GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Concord Medical Services Holdings Ltd (NYSE:CCM) » Definitions » 1-Year ROIIC %

CCM (Concord Medical Services Holdings) 1-Year ROIIC % : 1.21% (As of Jun. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Concord Medical Services Holdings 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Concord Medical Services Holdings's 1-Year ROIIC % for the quarter that ended in Jun. 2024 was 1.21%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Concord Medical Services Holdings's 1-Year ROIIC % or its related term are showing as below:

CCM's 1-Year ROIIC % is ranked better than
53.81% of 643 companies
in the Healthcare Providers & Services industry
Industry Median: -0.76 vs CCM: 1.21

Concord Medical Services Holdings 1-Year ROIIC % Historical Data

The historical data trend for Concord Medical Services Holdings's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Medical Services Holdings 1-Year ROIIC % Chart

Concord Medical Services Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
1-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.59 3.69 -14.35 0.43 12.51

Concord Medical Services Holdings Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -72.32 0.43 -22.12 12.51 1.21

Competitive Comparison of Concord Medical Services Holdings's 1-Year ROIIC %

For the Medical Care Facilities subindustry, Concord Medical Services Holdings's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Concord Medical Services Holdings's 1-Year ROIIC % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Concord Medical Services Holdings's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Concord Medical Services Holdings's 1-Year ROIIC % falls into.



Concord Medical Services Holdings 1-Year ROIIC % Calculation

Concord Medical Services Holdings's 1-Year ROIIC % for the quarter that ended in Jun. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -61.298 (Jun. 2024) - -62.6517 (Jun. 2023) )/( 950.532 (Jun. 2024) - 838.818 (Jun. 2023) )
=1.3537/111.714
=1.21%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Concord Medical Services Holdings  (NYSE:CCM) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Concord Medical Services Holdings 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Concord Medical Services Holdings's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Concord Medical Services Holdings Business Description

Traded in Other Exchanges
N/A
Address
Hanwei Building, No. 7 Guanghua Road, Room 26A1-26A5, East Area, Chaoyang District, Beijing, CHN, 100013
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high-intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.